ZNF700 Inhibitors
Chemical inhibitors of ZNF700 can lead to its functional inhibition through various molecular mechanisms. Staurosporine, a broad-spectrum protein kinase inhibitor, can disrupt the phosphorylation processes essential for ZNF700's function. Similarly, Bisindolylmaleimide I and GF109203X, both inhibitors of protein kinase C (PKC), can halt signaling pathways that ZNF700 relies on for its regulatory activities within the cell. LY294002 and Wortmannin, potent inhibitors of phosphoinositide 3-kinases (PI3K), can also impede the AKT signaling pathway, potentially affecting ZNF700's role in transcriptional regulation. These inhibitory actions can affect the post-translational modifications and signaling cascades necessary for ZNF700's activity.
Further, PD 98059 and U0126, specific inhibitors of MEK, can prevent the activation of the MAPK/ERK pathway, a pathway in which ZNF700 may be involved. SB203580, targeting p38 MAP kinase, and SP600125, inhibiting JNK, both act on different parts of the MAPK signaling pathways, which are known to regulate various transcription factors and proteins that ZNF700 might interact with. Rapamycin, an mTOR inhibitor, can disrupt cellular growth and protein synthesis processes that are essential for ZNF700's regulatory functions. Lastly, Y-27632, a ROCK inhibitor, can interfere with the cytoskeletal architecture, which is fundamental for the cellular context in which ZNF700 operates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. ZNF700, as a zinc finger protein, may rely on phosphorylation events for its activity or interactions with other proteins. Inhibition of these kinases can therefore lead to the functional inhibition of ZNF700 by preventing its necessary post-translational modifications. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is an inhibitor of protein kinase C (PKC). PKC is involved in signaling pathways that could be necessary for ZNF700's function, especially in cellular signaling and gene expression. Blocking PKC can thus inhibit the functional activity of ZNF700 indirectly by disrupting necessary signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K. PI3K is part of the AKT signaling pathway which might be crucial for the function of ZNF700, especially in processes such as transcriptional regulation. By inhibiting this pathway, LY294002 can functionally inhibit the activity of ZNF700. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK, which is involved in the MAPK/ERK pathway, a pathway that ZNF700 may utilize for its role in gene expression regulation. Inhibition of MEK would thus lead to functional inhibition of ZNF700 by preventing activation of downstream components that ZNF700 might act upon. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. The mTOR pathway is involved in cell growth and protein synthesis, and its inhibition can affect transcription factors and other proteins that are crucial for ZNF700's function, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. This kinase is involved in stress and inflammatory responses, and its inhibition can disrupt signaling pathways that are potentially necessary for ZNF700's regulatory functions, leading to functional inhibition of ZNF700. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK. JNK is part of the MAPK signaling pathways which can regulate transcription factors and other proteins that ZNF700 might interact with in the cell. Inhibiting JNK can thus lead to the functional inhibition of ZNF700 by disrupting its associated signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, which would prevent the activation of ERK, a pathway that ZNF700 could be involved in. Inhibition of this pathway would functionally inhibit ZNF700 by preventing the necessary signaling for its regulatory action. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases are involved in various signaling pathways that could intersect with ZNF700's function, particularly in gene expression regulation. Inhibiting these kinases could, therefore, lead to functional inhibition of ZNF700 by disrupting necessary protein-protein interactions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor, similar to LY294002. By inhibiting PI3K, wortmannin disrupts AKT signaling, which could be necessary for ZNF700's function in the cell, leading to its functional inhibition. | ||||||